Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03459352 · ClinicalTrials.gov registry record · NA
Digital Symptom Tracking, Patient Engagement and Quality of Life in GI Oncology Clinic Patients
A NA study of Cancer, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
- 1
- Study location
NCT03459352 is a NA study of Cancer that has completed, run by Duke University. The registered enrollment target is 38 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03459352, a NA study of Cancer, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
- 1
- Study location
Study Summary
A pilot study of an ePRO system in cancer patients receiving systemic therapies.
Conditions Studied
Interventions
- OTHER ePRO
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2018-06-18 |
| Est. Completion | 2020-04-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03459352
The ClinicalTrials.gov registry entry for NCT03459352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which ePRO is the first listed.
NCT03459352 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03459352 about?
NCT03459352 is a clinical study titled "Digital Symptom Tracking, Patient Engagement and Quality of Life in GI Oncology Clinic Patients". A pilot study of an ePRO system in cancer patients receiving systemic therapies.
What is the current status of trial NCT03459352?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2018-06-18. Estimated completion is 2020-04-04.
What conditions does trial NCT03459352 study?
This clinical trial studies the following conditions: Cancer.
What interventions are being tested in trial NCT03459352?
The interventions under investigation include: ePRO (OTHER).
Who is sponsoring clinical trial NCT03459352?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03459352 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
BfedBwell Optimization Pilot
RECRUITING · NA
-
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
RECRUITING · NA
-
Optimizing the AYA Survivors' Coping and Emotional Needs Toolkit
RECRUITING · NA
-
Comprehensive Connected Cancer Care (C4): Intervention Evaluation
RECRUITING · NA
-
Cancer-related Fatigue and Its Biological Contributors in Adolescent and Young Adult Brain Tumor Survivors: Effects of a Tele-exercise Intervention
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.